Biodistribution studies of anti-Thy 1.2 IgM immunoconjugates: Implications for radioimmunotherapy
- 1 August 1988
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 15 (2) , 383-389
- https://doi.org/10.1016/s0360-3016(98)90020-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Radioimmunotherapy with Alpha-Particle-Emitting ImmunoconjugatesScience, 1988
- ENGRAFTMENT FOLLOWING T-CELL-DEPLETED MARROW TRANSPLANTATIONTransplantation, 1987
- PREVENTION OF GRAFT FAILURE BY AN ANTI-HLFA-1 MONOCLONAL ANTIBODY IN HLA-MISMATCHED BONE-MARROW TRANSPLANTATIONThe Lancet, 1986
- The Depletion of T Cell Subsets in Vitro and in VivoTransplantation, 1986
- EXPERIMENTAL RADIOTHERAPY OF MURINE LYMPHOMA WITH I-131-LABELED ANTI-THY 1.1 MONOCLONAL-ANTIBODY1985
- COMPARISON OF THE SELECTIVE CYTO-TOXIC EFFECTS OF IMMUNOTOXINS CONTAINING RICIN-A CHAIN OR POKEWEED ANTIVIRAL PROTEIN AND ANTI-THY 1.1 MONOCLONAL-ANTIBODIES1984
- Thy-1 epitopes are expressed on murine myeloid leukemia and reticulum sarcoma cellsImmunology Letters, 1983
- A Conjugate of α-Amanitin and Monoclonal Immunoglobulin G to Thy 1.2 Antigen Is Selectively Toxic to T Lymphoma CellsScience, 1981
- Properties and Applications of Monoclonal Antibodies Directed against Determinants of the Thy-1 LocusThe Journal of Immunology, 1979
- Studies in vascular permeability. ii. comparative extravasation of different immunoglobulin classes in normal guinea pig skinEuropean Journal of Immunology, 1973